Jingyi Xiang
- Oncology top 5%
- CAR-T cell therapy research 7
- Immunology top 5%
- Immunotherapy and Immune Responses 2
- Genetics top 10%
- Virus-based gene therapy research 1
-
- Monoclonal and Polyclonal Antibodies Research 5
- Radiomics and Machine Learning in Medical Imaging 1
-
- Erythrocyte Function and Pathophysiology 2
-
- Glycosylation and Glycoproteins Research 1
- Protein Structure and Dynamics 1
- Cited by
- OncologyImmunologyGenetics
- Partner nations
- United StatesChinaSpain
In The Last Decade
Jingyi Xiang
14 papers receiving 988 citations
Hit Papers
Peers
Comparison fields: 5 of 58
- Oncology 808
- Immunology 452
- Genetics 192
- Radiology, Nuclear Medicine and Imaging 141
- Biomedical Engineering 246
Countries citing papers authored by Jingyi Xiang
This map shows the geographic impact of Jingyi Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingyi Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingyi Xiang more than expected).
Fields of papers citing papers by Jingyi Xiang
This network shows the impact of papers produced by Jingyi Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingyi Xiang. The network helps show where Jingyi Xiang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jingyi Xiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 0 | |
| 4 | 2021 | 1 | |
| 5 | 2019 | 0 | |
| 6 | Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivobreakdown → | 2018 | 628 |
| 7 | 2018 | 34 | |
| 8 | 2017 | 6 | |
| 9 | 2017 | 34 | |
| 10 | 2016 | 1 | |
| 11 | 2015 | 126 | |
| 12 | 2015 | 47 | |
| 13 | 2014 | 41 | |
| 14 | 2004 | 39 | |
| 15 | 2001 | 32 | |
| 16 | Intratumoral vaccination of adenoviruses expressing fusion protein RM4/tumor necrosis factor (TNF)-alpha induces significant tumor regression. | 1999 | 14 |
About Jingyi Xiang
Jingyi Xiang is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Physiology, having authored 16 papers that have together received 1.0k indexed citations. Recurring topics across this work include CAR-T cell therapy research (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Erythrocyte Function and Pathophysiology (2 papers), Immunotherapy and Immune Responses (2 papers), Radiomics and Machine Learning in Medical Imaging (1 paper), Glycosylation and Glycoproteins Research (1 paper), Virus-based gene therapy research (1 paper) and Protein Structure and Dynamics (1 paper). The work is most often cited by research in Oncology (808 citations), Immunology (452 citations) and Genetics (192 citations). Jingyi Xiang has collaborated with scholars based in United States, China and Spain. Frequent co-authors include Liu C, Su Yan, Pei Wang, Mei Song, Renier J. Brentjens, Sarwish Rafiq, Oladapo Yeku, Xiaojing Ma, Dylan J. Drakes and Dayenne G. van Leeuwen. Their work appears in journals such as Nature Communications, Blood and Nature Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.